Participated · Series C · Mar 2024

Overjet builds AI for dental organizations, offering FDA-cleared technology that serves as an objective standard for making oral health decisions. Its platform helps dentists detect pathologies with precision and aids patient education while reducing administrative overhead. Led by CEO Wardah Inam, the company intends to expand its AI platform to create the first unified standard for dental providers and payers. The company raised $53.2M in a Series C that brought total funding to approximately $133M and increased its valuation to $550M. Investors in the round included March Capital (lead), General Catalyst, Insight Partners, E14 Fund, Crosslink Capital, Spring Rock Capital, Liquid 2 Ventures, Harmonic Growth Partners, and the American Dental Association. Overjet plans to use the funds to accelerate its mission to improve patient outcomes and to make dental AI ubiquitous. Overjet develops dental artificial intelligence software that helps dentists interpret scans to identify disease and track progression. Its Dental Assist product has FDA clearance and the company focuses on deploying software to large dental groups, including a partnership with 50-clinic New England Family Dentistry. On the insurance side Overjet counts 16 major carriers as customers and expanded coverage from about 50 million members at the Series A to roughly 75 million now. The company moved to a remote-first model to broaden hiring and grew headcount from 20 to 50 in December, with plans to triple headcount in the next six months, especially in customer success and engineering. Overjet says it will use new funding to set up practice operations, develop new products, and implement its software into thousands of practices. Its stated focus is improving oral health by measuring disease progression and outcomes to support more value-based care. Overjet develops dental artificial intelligence products designed to help dentists deliver better patient care and enable dental insurers to operate more accurately and efficiently. The company recently received FDA clearance for its Dental Assist product intended for dental practices. Overjet raised $27M in a Series A round and has raised over $35M to date. The company says it will use the funds to accelerate market adoption and launch new products. The round was led by General Catalyst and Insight Partners, with participation from Crosslink Capital and the MIT-affiliated E14 Fund. Led by CEO and co-founder Dr. Wardah Inam and COO Shaju Puthussery, Overjet was founded by experts from MIT and the Harvard School of Dental Medicine and has assembled a team with deep AI, dental, and insurance experience. Overjet develops AI that analyzes dental x‑rays to determine the presence and extent of dental issues and to recommend necessary treatments. Its technology goes beyond flagging problems to estimating severity, which can aid both clinicians and insurers. The company positions its product to help dentists confirm diagnoses and to help insurers process and vet claims more quickly, potentially reducing fraud. Overjet charges insurance companies per claim analyzed and sells to dental practices on a SaaS model. The startup has been supported by two MIT groups and was incubated at the Harvard Innovation Lab, reflecting Boston‑area educational links. CEO Wardah Inam (an MIT PhD) says the company currently has around 20 employees and expects to grow this year.